ARCHIVES

Celgene Begins Two Studies With Hoffmann-La Roche.

This article is from The Cancer Letter archive.

Vol. 27 No. 26 | June 29, 2001

Download PDF Visit The Full Archive

Related Articles

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

November 7, 2003

Consortium Aims To Make Mice Whose Cancers Act Human.

January 7, 2000

Bernard Fisher Settles Suit For $2.7M, Retains title, University Apologizes

September 5, 1997

Frederick RFP Held Up; NCI Probably Will Reject Any Further Delay

October 15, 1976

NCA Approves New Guidelines For Comprehensive Review

December 8, 1989

Funding Opportunities: Lymphoma Foundation Offers Two-Year Fellowship Grants

July 31, 1998